Spanish Stock News

Iberdrola recently announced that its co-investment alliance with Norges Bank Investment Management has reached 1,500 MW of installed renewable capacity, marking a significant scale-up of their joint clean energy portfolio. This milestone underscores how partnering with a large institutional investor can help Iberdrola accelerate capital-intensive renewables build-out while sharing project risk. Next, we will examine how this expanded renewables footprint with Norges Bank Investment...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Vytrus Biotech, S.A. ( BME:VYT ) shares have continued their recent momentum with a 32% gain in the last month alone...

ESOP shelf registration puts new Banco Santander shares in focus Banco Santander (BME:SAN) has filed a US$326.5 million shelf registration for up to 25,000,000 American Depositary Receipts, tied to an employee stock ownership plan. This filing puts potential share issuance on investors’ radar. See our latest analysis for Banco Santander. At a share price of €11.048, Banco Santander has enjoyed firm momentum recently, with a 30 day share price return of 7.76% and a 90 day gain of 25.46%. Its 1...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

As the eurozone economy continues its modest recovery, bolstered by stronger investment and household consumption, the pan-European STOXX Europe 600 Index has shown resilience despite mixed performances among major stock indexes. In this environment of cautious optimism and improving confidence, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

While Grenergy Renovables, S.A. ( BME:GRE ) might not have the largest market cap around , it led the BME gainers with...

Meliá Hotels International, S.A. ( BME:MEL ), is not the largest company out there, but it saw a double-digit share...

Almirall has reported that China’s National Medical Products Administration approved Seysara (sarecycline hydrochloride) for treating inflammatory lesions of non-nodular moderate-to-severe acne in patients aged 9 and older, with Sinomune holding exclusive commercialization and distribution rights in China. This marks the first approval in China of a tetracycline-derived oral antibiotic developed specifically for dermatology, expanding Seysara’s reach beyond its earlier US launch and...

As the eurozone economy continues its modest recovery, with consumer and business confidence on the rise, European markets present a fertile ground for discovering promising investment opportunities. In this environment of cautious optimism and economic resilience, identifying stocks that demonstrate strong fundamentals and growth potential can be particularly rewarding for investors seeking to capitalize on Europe's evolving market landscape.

In recent days, Santander UK confirmed plans to close 44 branches by January 2027, putting 291 jobs at risk as 96% of transactions have shifted online and more services move to digital channels and shared banking hubs. This consolidation of the physical network, paired with the use of “community bankers” and banking hubs, signals a meaningful reset in how Santander balances cost control with maintaining local access to cash and face-to-face support. Next, we’ll examine how this branch...

What the Seysara approval in China means for Almirall Almirall (BME:ALM) is back on investors radar after China approved its dermatology focused oral antibiotic Seysara for moderate to severe acne, alongside a new licensing and distribution deal with Sinomune. See our latest analysis for Almirall. The Seysara approval appears to have come at a time when momentum has been mixed, with a recent 1 day share price return of 2.77% contrasting with a 30 day share price return decline of 2.17%, while...

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...

Key Insights The considerable ownership by retail investors in Acerinox indicates that they collectively have a greater...

Why CaixaBank's latest earnings matter for shareholders CaixaBank (BME:CABK) is back in focus after reporting record 2025 net profit of €5.891b, outlining higher medium term return targets, and flagging room for additional share buybacks alongside a larger dividend proposal. See our latest analysis for CaixaBank. The strong full year earnings update, higher dividend proposal and talk of further buybacks have gone hand in hand with a sharp move in CaixaBank’s shares, with a 6.75% 1 day share...

Banco Bilbao Vizcaya Argentaria has recently advanced its multi-stage share buyback programme while also facing a downgrade from RBC Capital, which cited valuation concerns despite strong past performance and profitability. At the same time, short interest in BBVA has risen and the bank is exploring a sale of its Garanti Bank Romania unit amid ongoing support from European institutions for SME and sustainable housing financing. With these developments and BBVA’s continuing share buyback in...

If you are wondering whether Neinor Homes shares still offer value after a strong run, this article will walk through what the current price might be implying. The stock last closed at €20.10, with returns of 4.8% over 7 days, 5.8% over 30 days, 6.5% year to date and 29.5% over 1 year, while the 3 year and 5 year returns sit at 179.3% and 189.5% respectively. Recent attention around Neinor Homes has focused on its share price performance and how the company fits into Spain's residential...

Why Metrovacesa’s latest Madrid office deal matters for shareholders Metrovacesa (BME:MVC) has agreed a €200 million turnkey sale to Atrea for two office buildings in Madrid, completing commercialisation of the Oria Innovation Campus and filling a key slot in its development pipeline. See our latest analysis for Metrovacesa. Metrovacesa’s €200 million Atrea deal lands at a time when momentum in the shares has picked up again, with a 1 month share price return of 11.11% helping offset a 10.73%...

Bankinter, S.A. reported its fourth-quarter 2025 results, with net interest income rising to €576.38 million and net income reaching €278.47 million, both higher than a year earlier. The combination of higher net interest income and stronger bottom-line profitability highlights how Bankinter’s core lending business contributed to improved earnings quality. We’ll now examine how this stronger net income performance shapes Bankinter’s investment narrative and what it may signal for...

CaixaBank, S.A. has released its full-year 2025 results, reporting net interest income of €10,732 million versus €11,208 million a year earlier, while net income edged up to €5,891 million from €5,787 million. This combination of lower net interest income but higher net income highlights how CaixaBank’s business mix and cost factors influenced overall profitability in 2025. We’ll now examine how CaixaBank’s higher net income despite lower net interest income shapes the company’s investment...

Santander plans to close 44 branches in the UK, putting nearly 300 jobs at risk. The closures are part of a shift toward digital banking and a wider cost cutting program. The bank is introducing community banking alternatives to maintain some local presence in affected areas. The decision coincides with the final phase of UK chief Mike Regnier’s tenure. For investors watching Banco Santander (BME:SAN), these closures sit alongside a share price of €10.78 and very large multi year returns,...

If you are wondering whether Banco Bilbao Vizcaya Argentaria is attractively priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock last closed at €21.45, with stated returns of 1.8% over 7 days, 7.0% over 30 days, 5.3% year to date and 103.3% over 1 year, plus a very large 3 year return and a more than 7x 5 year return. This naturally raises questions about how much upside or risk is now priced in. Recent coverage...

Repsol has announced plans to install its second large-scale electrolyser, a 100 MW unit at the Petronor refinery in Muskiz, Vizcaya, expected to be operational in 2029 and capable of producing up to 15,000 tonnes of renewable hydrogen annually for refinery use and local industry. As part of the Basque Hydrogen Corridor, this project is positioned to support regional industrial decarbonization by supplying renewable gas and could help avoid up to 167,000 tonnes of CO2 emissions each...

Neinor Homes (BME:HOME) has drawn investor interest after recent share price gains over the past month and the past 3 months, prompting a closer look at how its current valuation lines up with fundamentals. See our latest analysis for Neinor Homes. Those near term share price returns of 1.8% over one day and 7.2% over 30 days sit alongside a 16.7% 90 day share price return and a 30% one year total shareholder return. Together, these point to building momentum around the €20.15 share price. If...